Lista de obras - Jorge Lima - Dominio Público Uruguay

A [Glyco]biomarker that Predicts Failure to Standard Therapy in Ulcerative Colitis Patients

artículo científico publicado en 2019

A founder SDHB mutation in Portuguese paraganglioma patients

article

A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney–Stratakis dyad

artículo científico publicado en 2012

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

artículo científico publicado en 2003

GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma

artículo científico publicado en 2016

GRIM-19 in Health and Disease.

artículo científico publicado en 2008

Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas

artículo científico publicado en 2011

Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia.

artículo científico publicado en 2003

High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations

artículo científico publicado en 2007

Hypoxia Pathway Mutations in Pheochromocytomas and Paragangliomas

artículo científico publicado en 2017

Impact of EGFR genetic variants on glioma risk and patient outcome.

artículo científico publicado en 2011

Intragenic mutations in thyroid cancer.

scientific article published on June 2008

Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone.

artículo científico publicado en 2011

Malignant paraganglioma and somatotropinoma in a patient with germline SDHB mutation-genetic and clinical features

scientific article published on 28 August 2018

Metabolic traits of cancer stem cells.

artículo científico publicado en 2018

Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy

scientific article published on 01 October 2005

Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.

artículo científico publicado en 2012

OXPHOS dysfunction regulates integrin-β1 modifications and enhances cell motility and migration.

artículo científico publicado en 2014

Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment

artículo científico publicado en 2018

Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas

artículo científico publicado en 2005

STAT3 negatively regulates thyroid tumorigenesis

scientific journal article

Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.

artículo científico publicado en 2005

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas

artículo científico publicado en 2014

Telomerase promoter mutations in cancer: an emerging molecular biomarker?

artículo científico publicado en 2014

The biology and the genetics of Hurthle cell tumors of the thyroid.

artículo científico publicado en 2012

The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk

artículo científico publicado en 2014

The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.

artículo científico publicado en 2016

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness

artículo científico publicado en 2005

Lista de obras de Jorge Lima

A [Glyco]biomarker that Predicts Failure to Standard Therapy in Ulcerative Colitis Patients

A founder SDHB mutation in Portuguese paraganglioma patients

A novel germline SDHB mutation in a gastrointestinal stromal tumor patient without bona fide features of the Carney–Stratakis dyad

BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC

GLUT1, MCT1/4 and CD147 overexpression supports the metabolic reprogramming in papillary renal cell carcinoma

GRIM-19 in Health and Disease.

Genetic alterations in poorly differentiated and undifferentiated thyroid carcinomas

Germline succinate dehydrogenase subunit D mutation segregating with familial non-RET C cell hyperplasia.

High frequency of germline succinate dehydrogenase mutations in sporadic cervical paragangliomas in northern Spain: mitochondrial succinate dehydrogenase structure-function relationships and clinical-pathological correlations

Hypoxia Pathway Mutations in Pheochromocytomas and Paragangliomas

Impact of EGFR genetic variants on glioma risk and patient outcome.

Intragenic mutations in thyroid cancer.

Involvement of p53 in cell death following cell cycle arrest and mitotic catastrophe induced by rotenone.

Malignant paraganglioma and somatotropinoma in a patient with germline SDHB mutation-genetic and clinical features

Metabolic traits of cancer stem cells.

Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy

Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.

OXPHOS dysfunction regulates integrin-β1 modifications and enhances cell motility and migration.

Receptor-mediated PLGA nanoparticles for glioblastoma multiforme treatment

Reply to: Low prevalence of BRAF mutations in radiation-induced thyroid tumors in contrast to sporadic papillary carcinomas

STAT3 negatively regulates thyroid tumorigenesis

Somatic and germline mutation in GRIM-19, a dual function gene involved in mitochondrial metabolism and cell death, is linked to mitochondrion-rich (Hurthle cell) tumours of the thyroid.

TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas

Telomerase promoter mutations in cancer: an emerging molecular biomarker?

The biology and the genetics of Hurthle cell tumors of the thyroid.

The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk

The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism.

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness